Medical imaging

First IBA Dosimetry Dolphin® Transmission Detector in Brazil advancing patient safety in radiation therapy

November 16, 2018

Innovative Dolphin® patient QA solution and myQA® have been clinically implemented at the Radion Institute in Curitiba, Brazil, ensuring high quality and save radiation therapy.


Curitiba, Brazil, November 13, 2018 – IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the first clinical implementation of Dolphin Online Ready Patient QA solution in Brazil.

With the use of Dolphin, the radiation therapy team at the Radion Institute implemented a new quality assurance standard for challenging radiation therapy and Stereotactic Body Radiation Therapy (SBRT) cases. To bring patient safety to a new level in Brazil, the hospital’s team can now review treatment doses using Dolphin’s 3D dose verification within the patient’s individual anatomy.

“Patient safety and confidence in treatment accuracy are the main reasons for clinically implementing Dolphin at our institution”, said Dr. José Carlos Gasparin Pereira, Radiation Oncologist and Director of Radiotherapy at Radion. “We are now able to detect even minimal deviation between the treatment plan and the radiation beams for each individual patient, allowing us to define corrective actions without distracting from the patient’s treatment. This allows us to offer a new standard of quality and safety to our patients.”

Alongside Dolphin, Radion Institute also implemented IBA Dosimetry’s myQA global QA platform to streamline all quality assurance modalities in one solution.

“We needed a quality assurance tool that would keep up with latest treatment delivery trends. With Dolphin, advanced treatments such as VMAT, SBRT and cranial radiosurgery can be measured and evaluated quickly and efficiently”, said Ricardo Goulart, Physicist at the Radion Institute. “The seamless integration of Dolphin as well as myQA machine tests allowed us to implement a state of the art QA program without difficulties.”

“We are very impressed by the work achieved by the team at Radion Institute and we are very proud to be partners, to contribute to quality assurance and patient safety at the highest standards in
Brazil,” said Jean-Marc Bothy, President of IBA Dosimetry GmbH. To find out more please visit